Renaissance Technologies’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-2,540,200
| Closed | -$27.9M | – | 3506 |
|
|
2017
Q2 | $27.9M | Buy |
2,540,200
+456,100
| +22% | +$5.02M | 0.04% | 655 |
|
|
2017
Q1 | $20.4M | Buy |
2,084,100
+314,202
| +18% | +$3.08M | 0.03% | 786 |
|
|
2016
Q4 | $19.1M | Buy |
1,769,898
+384,898
| +28% | +$4.16M | 0.03% | 822 |
|
|
2016
Q3 | $14.2M | Buy |
1,385,000
+223,300
| +19% | +$2.29M | 0.03% | 937 |
|
|
2016
Q2 | $15.2M | Buy |
1,161,700
+229,400
| +25% | +$3M | 0.03% | 872 |
|
|
2016
Q1 | $10.3M | Buy |
932,300
+349,220
| +60% | +$3.84M | 0.02% | 1122 |
|
|
2015
Q4 | $5.36M | Buy |
583,080
+139,580
| +31% | +$1.28M | 0.01% | 1425 |
|
|
2015
Q3 | $3.08M | Sell |
443,500
-248,160
| -36% | -$1.72M | 0.01% | 1712 |
|
|
2015
Q2 | $6.79M | Buy |
691,660
+251,260
| +57% | +$2.47M | 0.02% | 1220 |
|
|
2015
Q1 | $3.9M | Buy |
440,400
+240,980
| +121% | +$2.14M | 0.01% | 1519 |
|
|
2014
Q4 | $1.75M | Buy |
199,420
+113,520
| +132% | +$994K | ﹤0.01% | 1877 |
|
|
2014
Q3 | $592K | Sell |
85,900
-235,426
| -73% | -$1.62M | ﹤0.01% | 2253 |
|
|
2014
Q2 | $1.69M | Buy |
321,326
+58,319
| +22% | +$307K | ﹤0.01% | 1811 |
|
|
2014
Q1 | $1.2M | Buy |
263,007
+28,103
| +12% | +$128K | ﹤0.01% | 2000 |
|
|
2013
Q4 | $1.18M | Sell |
234,904
-271,196
| -54% | -$1.37M | ﹤0.01% | 1994 |
|
|
2013
Q3 | $2.57M | Buy |
506,100
+370,300
| +273% | +$1.88M | 0.01% | 1538 |
|
|
2013
Q2 | $674K | Buy |
+135,800
| New | +$674K | ﹤0.01% | 2109 |
|